In 2021, the World Health Organization updated their CNS tumor classification to include two categories of these pLGGs: angiocentric glioma with MYB-QKI fusions and diffuse astrocytoma with various MYB/MYBL1 alterations [4]. This evidence concerns the gene MYB and diffuse astrocytoma.